MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics - Test2 - elhamkhani - TriplyDB

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

http://www.wikidata.org/entity/Q26747273

about

The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA.Transfer of functional microRNAs between glioblastoma and microvascular endothelial cells through gap junctions.The miR-24-3p/p130Cas: a novel axis regulating the migration and invasion of cancer cells.MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.A new function for miRNAs as regulators of autophagy.Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis.TGF-â1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease Treatment A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2.microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.Serum microRNA profiling in patients with glioblastoma: a survival analysis.MicroRNA-target cross-talks: Key players in glioblastoma multiforme.SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.miR-24-3p/FGFR3 Signaling as a Novel Axis Is Involved in Epithelial-Mesenchymal Transition and Regulates Lung Adenocarcinoma Progression.Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

P2860

Q28554467-0332FF20-D6E7-466A-BAF5-DEEEB70963EB Q36316457-9A78B095-0C41-47C5-8AAC-DCF56738E98A Q37687500-011BFFD2-BB8E-4A4A-928C-AC6EBD39ACDC Q37719430-0EB8FDBF-854D-431C-877C-9B55EDC8AAA3 Q38768383-01BB54A3-7F35-4EBC-9BF4-069E54F86AC4 Q38783633-0549B96F-AF69-4683-BBF1-0B955B645324 Q38847110-B81FA365-9DB5-41DE-804D-A4E03BE3613C Q41048323-A77DD551-AB30-4F7B-B96F-78D44496FCD0 Q41208796-2BD1AEB1-1FC1-4F67-A9CF-0A6469A2117E Q41243197-E76F239C-E62B-46A6-9F9B-DBEC8E426625 Q41364290-98CCD115-7C0B-4542-8C74-16A7543CD579 Q41920847-E363268C-0549-4443-A590-DAF54C219489 Q42056934-25053BA1-B56A-4AFB-89C8-8D669ED08039 Q42317085-EB97313E-E03D-4BB8-9587-99FE9BE58A7B Q46190130-29733B0E-2360-4344-88E0-32DD984E4BB0 Q48412285-16FF34CB-7A3E-4402-B56C-A42937ACAAA0 Q52366335-8BFDF2E1-6B30-4C22-A13E-4F39A3C95FE1 Q55040613-2FA28A73-DB2F-4AED-93FC-07CCC2D79113 Q57153312-24697C96-11CB-4C67-ADCD-DED6D88313E2

P2860

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

http://www.wikidata.org/entity/Q26747273

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@ast

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@en

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@nl

type

label

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@ast

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@en

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@nl

prefLabel

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@ast

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@en

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@nl

P1433

Q26747273-0D0E056E-5BA3-4A85-B081-43C72E283306

P1476

Q26747273-91E9C162-5DFA-41B3-BD4B-E1AD35D6E446

P2093

Q26747273-021116ED-CF8D-4240-A511-46B05EB0E8D9

Q26747273-15AC2062-AD20-463A-8DB2-78CE256AA83E

Q26747273-242A471C-F094-4BCF-8CB5-26810AB1A423

Q26747273-322D4714-A4B9-47E4-ACF8-37391B776B9A

Q26747273-4076C9CE-5A0B-4AC3-8591-996D203826AD

Q26747273-6969ECF5-089A-4F99-82E9-166203AD10EF

Q26747273-8DB598CA-E572-45ED-9008-C6D4178CF573

Q26747273-BE97C112-DABC-4443-A08B-DE33CFC794C7

Q26747273-D9AA3F72-F44A-4A2F-B526-E04D9A712845

Q26747273-DC8D1CE5-2AAD-4CE3-B930-6C6F7C660743

P275

Q26747273-DAADAC87-C825-4B69-8675-D804CD72605C

P2860

Q26747273-006BCEA0-5AD3-42A8-AA0E-3EEEC84E8BED

Q26747273-01BE39F1-48B3-4929-90E2-63C5B71C70E3

Q26747273-037A514C-0D9C-480D-82FF-09A4A8E26E00

Q26747273-04EB2CAF-584F-4994-BBD2-1D366730B06C

Q26747273-052004AA-EE2B-4E75-948B-CFFB0F33F400

Q26747273-0555492E-E1C5-4AE3-AE51-00D095D42738

Q26747273-05554DD3-1F00-41D2-9D84-103CD9F6B888

Q26747273-056ADEA8-1B6D-4B11-A976-7BCFBFCCF0F2

Q26747273-070BFAC8-637C-4010-87E6-31575C5C8034

Q26747273-07154737-050B-4034-BEC7-3F13F007332B

P304

Q26747273-B7352420-F680-47B9-8C38-F800F17C9BE9

P31

Q26747273-8D6872C7-BF63-4C66-A43B-8D36658C0298

P3181

Q26747273-43CC2F05-55B0-46AD-9E0D-156C758E0E86

P356

Q26747273-D86E32F8-F6E1-41AD-8780-2659014F66B3

P407

Q26747273-6B83E614-0B8F-4DE5-96BE-93BD992118D4

P433

Q26747273-A13AF80F-39DC-4D92-954A-8AB907B0E7C7

P478

Q26747273-A3258640-29BC-43BD-9CE7-F7EBEBAEDC3E

P50

Q26747273-5F70B997-5054-4B58-A06F-E4D7F774C1DF

P5008

Q26747273-9A72843D-6522-4E10-9443-A4AABB2B1581

P577

Q26747273-D62703C3-FF07-4252-B2DD-C19C2E9A055D

P698

Q26747273-0B16077A-E6D9-4D57-80A4-D19AE6CAC701

P921

Q26747273-02D8F338-7E2D-40C8-BDA0-E7FF7181B972

Q26747273-0C7DB0BE-D276-4831-9C36-FEBFF269C137

Q26747273-2AEE9148-305D-4112-8B2A-751D9CAD861C

Q26747273-A5212C02-8532-4779-91F5-72ADE0168B35

Q26747273-E2A64E75-6F7F-48DD-ADBC-E5C1FC0F0DE8

Q26747273-FC0ED35B-C0DA-4191-9C08-9BB8E5F3CB87

P932

Q26747273-20B649CF-10FA-46E8-85E3-E8F5FAB3B510

P3181

P356

P1433

Cancer Medicine

P1476

MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

@en

P2093

Arpita Roy

http://www.w3.org/2001/XMLSchema#string

Brent Harris

http://www.w3.org/2001/XMLSchema#string

Deepak Kumar

http://www.w3.org/2001/XMLSchema#string

Habib Kedir

http://www.w3.org/2001/XMLSchema#string

Jan Blancato

http://www.w3.org/2001/XMLSchema#string

Juliet Chijioke

http://www.w3.org/2001/XMLSchema#string

Malathi Ramalinga

http://www.w3.org/2001/XMLSchema#string

Mukesh Verma

http://www.w3.org/2001/XMLSchema#string

Shahnoza Dusmatova

http://www.w3.org/2001/XMLSchema#string

Varsha Harish

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Role of microRNA-26b in glioma development and its mediated regulation on EphA2

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

The nuclear RNase III Drosha initiates microRNA processing

Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs

The Drosha-DGCR8 complex in primary microRNA processing

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing

P304

1917-1946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1330128

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/CAM4.775

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27282910

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

4971921

http://www.w3.org/2001/XMLSchema#string